Difference between revisions of "Non-invasive breast carcinoma"

Non-invasive breast carcinoma (view source)

837 bytes removed , 05:39, 28 November 2016

48,868

edits

@@ Line 100: / Line 100: @@
 ==Atypical lobular hyperplasia==
 *Abbreviated ''ALH''.
+{{Main|Atypical lobular hyperplasia}}
-===General===
-*May occur with ''ductal involvement by cells of atypical lobular hyperplasia'' (abbreviated ''DIALH'').<ref name=pmid3343034>{{Cite journal  | last1 = Page | first1 = DL. | last2 = Dupont | first2 = WD. | last3 = Rogers | first3 = LW. | title = Ductal involvement by cells of atypical lobular hyperplasia in the breast: a long-term follow-up study of cancer risk. | journal = Hum Pathol | volume = 19 | issue = 2 | pages = 201-7 | month = Feb | year = 1988 | doi =  | PMID = 3343034 }}</ref>
-**ALH with DIALH has a risk of developing breast cancer that is similar to [[LCIS]].
-===Microscopic===
-Features:
-*Extent criterium: <50% of terminal duct lobular unit (TDLU) is involved.
-*See ''[[lobular carcinoma in situ]]'' for details.
-DDx:
-*[[Lobular carcinoma in situ]].
-*[[Lobular carcinoma]].
-===IHC===
-*E-cadherin -ve ''or'' incomplete membrane staining.
 ==Lobular carcinoma in situ==